5038 Stock Overview
Develops business support cloud services for visiting nursing stations in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 6/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
eWeLL Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,665.00 |
| 52 Week High | JP¥2,240.00 |
| 52 Week Low | JP¥1,054.00 |
| Beta | 0 |
| 11 Month Change | 11.52% |
| 3 Month Change | 30.38% |
| 1 Year Change | -19.95% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -14.83% |
Recent News & Updates
Shareholder Returns
| 5038 | JP Healthcare Services | JP Market | |
|---|---|---|---|
| 7D | 18.1% | 7.1% | 6.1% |
| 1Y | -20.0% | -45.6% | 15.6% |
Return vs Industry: 5038 exceeded the JP Healthcare Services industry which returned -45.6% over the past year.
Return vs Market: 5038 underperformed the JP Market which returned 15.6% over the past year.
Price Volatility
| 5038 volatility | |
|---|---|
| 5038 Average Weekly Movement | 10.9% |
| Healthcare Services Industry Average Movement | 7.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in JP Market | 10.0% |
| 10% least volatile stocks in JP Market | 3.4% |
Stable Share Price: 5038's share price has been volatile over the past 3 months.
Volatility Over Time: 5038's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 67 | Norito Nakano | ewell.co.jp |
eWeLL Co.,Ltd. develops business support cloud services for visiting nursing stations in Japan. It also provides iBow, a SaaS-type business support tool that contributes to improving customer productivity; iBow receipt, a receipt system exclusively for visiting nursing that has the function of making insurance claims; iBow KINTAI a dedicated nursing attendance system; and iBow Nursing Care Claim Transmission Service.
eWeLL Co.,Ltd. Fundamentals Summary
| 5038 fundamental statistics | |
|---|---|
| Market cap | JP¥24.97b |
| Earnings (TTM) | JP¥688.00m |
| Revenue (TTM) | JP¥2.30b |
36.3x
P/E Ratio10.8x
P/S RatioIs 5038 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5038 income statement (TTM) | |
|---|---|
| Revenue | JP¥2.30b |
| Cost of Revenue | JP¥510.00m |
| Gross Profit | JP¥1.79b |
| Other Expenses | JP¥1.11b |
| Earnings | JP¥688.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 45.88 |
| Gross Margin | 77.86% |
| Net Profit Margin | 29.86% |
| Debt/Equity Ratio | 4.6% |
How did 5038 perform over the long term?
See historical performance and comparison